Analysis of Regional Timelines To Set Up a Global Phase III Clinical Trial in Breast Cancer: The Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Experience

PURPOSE. This study measured the time taken for setting up the different facets of Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization (ALTTO), an international phase III study being conducted in 44 participating countries. METHODS. Time to regulatory authority (RA) approval, time to ethics...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Metzger-Filho, Otto, de Azambuja, Evandro, Bradbury, Ian, Saini, Kamal S., Bines, José, Simon, Sergio D., Dooren, Veerle Van, Aktan, Gursel, Pritchard, Kathleen I., Wolff, Antonio C., Smith, Ian, Jackisch, Christian, Lang, Istvan, Untch, Michael, Boyle, Frances, Xu, Binghe, Baselga, Jose, Perez, Edith A., Piccart-Gebhart, Martine
Format: Artigo
Sprache:Inglês
Veröffentlicht: AlphaMed Press 2013
Schlagworte:
Breast Cancer
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3579596/
https://ncbi.nlm.nih.gov/pubmed/23359433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0342
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge